JMP Securities Maintains Market Outperform on Macrogenics, Raises Price Target to $10

Benzinga · 05/11/2023 10:56
JMP Securities analyst Silvan Tuerkcan maintains Macrogenics (NASDAQ:MGNX) with a Market Outperform and raises the price target from $8 to $10.